Page last updated: 2024-09-03

4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid and Acute Promyelocytic Leukemia

4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid has been researched along with Acute Promyelocytic Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, DL; Dawson, MI; Elstner, E; Kerner, B; Kizaki, M; Koeffler, HP; Pakkala, S1

Other Studies

1 other study(ies) available for 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid and Acute Promyelocytic Leukemia

ArticleYear
Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway.
    Blood, 1994, Jul-15, Volume: 84, Issue:2

    Topics: Animals; Cell Differentiation; Cell Division; Humans; Leukemia, Promyelocytic, Acute; Mice; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Retinoids; Transcription Factors; Tumor Cells, Cultured

1994